Text this: Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, a phase IIa, open-label study

   _____   _    _    _    _    _    _     _  _   
  / ___// | || | || | |  | || | || | ||  | \| || 
  \___ \\ | || | || | |/\| || | || | ||  |  ' || 
  /    // | \\_/ || |  /\  || | \\_/ ||  | .  || 
 /____//   \____//  |_// \_||  \____//   |_|\_|| 
`-----`     `---`   `-`   `-`   `---`    `-` -`